Skip to main content
. 2006 Apr 19;2006(2):CD005119. doi: 10.1002/14651858.CD005119.pub2

Matkovic 2004.

Methods STUDY DESIGN: randomised controlled trial 
 LOCATION AND SETTING: Community (school), USA 
 DURATION OF SUPPLEMENTATION: 7 years 
 DURATION OF FOLLOW‐UP: 7 years 
 QUALITY ASSESSMENT: High risk of bias 
 RANDOMISED: States random but no description 
 ALLOCATION CONCEALMENT: Not described or unclear 
 BLINDING OF SUBJECT: Yes 
 DESCRIPTION OF WITHDRAWALS/DROPOUTS: No
TYPE OF ANALYSIS: Available Data 
 COMPLIANCE: Assessed 
 CONFOUNDERS MEASURED: physical activity; dietary calcium, protein, energy intake; 24 hour urinary sodium; skeletal age, urinary and fecal calcium, serum calcium, serum vitamin D.
Participants N SCREENED: unknown 
 N RANDOMISED: 354 
 N COMPLETED: 220 (4 year); 179 (7 years) 
 M=0% 
 F=100% 
 ETHNICITY: white 
 MEAN BASELINE AGE (yrs): 10.8 
 BASELINE AGE RANGE (yrs): unknown 
 INCLUSION CRITERIA: white, normal physical and mental health, pubertal stage 2, calcium intake <1480 mg/day, female 
 EXCLUSION CRITERIA: history of metabolic bone, kidney, liver or celiac disease; use of oral corticosteroids, hormones, diuretics or antiseizure medications,; other current systemic, chronic disease; and the presence of clinically significant abnormal laboratory data on screening 
 BASELINE CALCIUM INTAKE (mg/day): 837 
 PUBERTAL STAGE: peripubertal (Tanner stage 2)
Interventions 1. 1000 mg/day calcium as calcium citrate malate 
 2. Placebo 
 CO‐INTERVENTIONS: Nil
Outcomes BONE MEASURES: SITES 
 AREAL BONE MINERAL DENSITY: distal radius, radius at 33% of the radius length, total body. 
 BONE AREA: distal radius, radius at 33% of the radius length, total body. 
 METHOD OF MEASUREMENT: DXA 
 FOLLOW‐UP ASSESSMENT POINTS(yrs): 0, 1, 2, 4.5, 8.5 
 OTHER OUTCOMES MEASURED: metacarpal cortical index at 4 and 7 years, weight, height, body composition, serum osteocalcin and PTH and urinary N‐telopeptides. 
 BONE MEASURES INCLUDED IN ANALYSES: 
 AREAL BONE MINERAL DENSITY: distal radius, radius at 33% of the radius length, total body. 
 BONE AREA: distal radius, radius at 33% of the radius length, total body. 
 SUB‐GROUPS IDENTIFIED: nil
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear